Flora Growth Corp (FLGC)
1.43
+0.12
(+9.16%)
USD |
NASDAQ |
Nov 22, 16:00
1.40
-0.03
(-2.10%)
After-Hours: 20:00
Flora Growth Revenue (Quarterly): 12.46M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.46M |
| June 30, 2024 | 15.68M |
| March 31, 2024 | 18.03M |
| December 31, 2023 | 17.98M |
| September 30, 2023 | 17.32M |
| June 30, 2023 | 21.46M |
| March 31, 2023 | 19.32M |
| Date | Value |
|---|---|
| December 31, 2022 | 10.55M |
| September 30, 2022 | 9.707M |
| June 30, 2022 | 8.943M |
| March 31, 2022 | 4.946M |
| December 31, 2021 | 4.769M |
| September 30, 2021 | 2.093M |
| June 30, 2021 | 1.159M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.159M
Minimum
Jun 2021
21.46M
Maximum
Jun 2023
11.74M
Average
11.51M
Median
Revenue (Quarterly) Benchmarks
| MariMed Inc | 40.59M |
| cbdMD Inc | 5.174M |
| Bright Green Corp | -- |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.773M |
| Total Expenses (Quarterly) | 15.70M |
| EPS Diluted (Quarterly) | -0.28 |
| Enterprise Value | 18.08M |
| Gross Profit Margin (Quarterly) | 22.78% |
| Profit Margin (Quarterly) | -30.27% |
| Earnings Yield | -118.2% |
| Normalized Earnings Yield | -49.86 |